We are live on
!
Find out more
CNFG
Creegan & Nassoura Financial Group Portfolio holdings
AUM
$154M
1-Year Est. Return
17.18%
This Fund
S&P 500
This Quarter
Est. Return
-11.11%
1 Year Est. Return
+17.18%
3 Year Est. Return
+52.61%
5 Year Est. Return
+77.6%
10 Year Est. Return
–
AUM
$119M
AUM Growth
-$14.4M
(-11%)
Cap. Flow
+$2.39M
Cap. Flow
% of AUM
2.01%
Top 10 Holdings %
Top 10 Hldgs %
30.62%
Holding
77
New
1
Increased
11
Reduced
40
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab US Dividend Equity ETF
SCHD
|
+$1.11M |
| 2 |
3M
MMM
|
+$1.09M |
| 3 |
JPMorgan Chase
JPM
|
+$1.06M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$875K |
| 5 |
Walt Disney
DIS
|
+$206K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sanofi
SNY
|
+$472K |
| 2 |
Amazon
AMZN
|
+$336K |
| 3 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$214K |
| 4 |
K
Kellanova
K
|
+$213K |
| 5 |
Vanguard Morningstar Large-Cap ETF
VV
|
+$208K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.07% |
| 2 | Industrials | 16.86% |
| 3 | Financials | 16.3% |
| 4 | Consumer Staples | 13.15% |
| 5 | Technology | 7.94% |
Similar funds
SW
USWG
SA
CWA
ACA
AIMU
PWA
ACMC
Creegan & Nassoura Financial Group's Q2 2022 Portfolio in Review
As of Q2 2022, Creegan & Nassoura Financial Group held 77 positions worth $119M, down 11% from $133M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Creegan & Nassoura Financial Group's Q2 2022 filing shows 1 new, 11 increased, 40 reduced and 4 closed positions. Its largest new stake was Schwab US Dividend Equity ETF: 43,557 shares worth $1.04M. The largest sale was Sanofi, an estimated $472K.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Financials.
- Creegan & Nassoura Financial Group's largest Q2 2022 buy was Schwab US Dividend Equity ETF: 43,557 shares worth $1.04M.
- Creegan & Nassoura Financial Group added most to 3M in Q2 2022, an estimated $1.09M increase.
- Creegan & Nassoura Financial Group's biggest Q2 2022 reduction was Kellanova, cutting an estimated $213K.
- Creegan & Nassoura Financial Group fully exited Sanofi in Q2 2022, selling an estimated $472K.
- Creegan & Nassoura Financial Group's ten largest holdings make up 31% of its $119M portfolio in Q2 2022.
- Creegan & Nassoura Financial Group opened 1 new position and closed 4 in Q2 2022.
- Creegan & Nassoura Financial Group's portfolio value fell 11% quarter-over-quarter to $119M.
Based on Creegan & Nassoura Financial Group's 13F filing for Q2 2022, filed 15 Aug 2022.